Clinical Trials List
Protocol Number13337
Not yet recruiting
2009-02-01 - 2010-08-31
Phase II
Terminated3
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Jian-Ri Li Division of Urology
- Chi-Rei Yang Division of Urology
- Shian-Shiang Wang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉詩彬 Division of Urology
- Yeong-Shiau Pu Division of Urology
- - - Division of Urology
- SHUO-MENG WANG Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsiao-Jen Chung Division of Urology
- Yi-Hsiu Huang Division of Urology
- Tzu-Ping Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
220 participants
